Allurion Technologies (ALUR) Share-based Compensation (2022 - 2026)
Allurion Technologies posted quarterly Share-based Compensation of $638000.0 for Q1 2026, down 28.87% year-on-year from $897000.0 in Q1 2025, and down 9.12% on a QoQ basis from $702000.0 in Q4 2025.
Allurion Technologies (ALUR) has 5 years of Share-based Compensation data on file, last reported at $638000.0 in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation fell 28.87% year-over-year to $638000.0; the trailing twelve-month figure through Mar 2026 stood at $2.9 million (down 15.11% YoY), and the FY2025 full-year result was $3.1 million, up 2.95% from the prior year.
- Share-based Compensation for Q1 2026 stood at $638000.0, down from $702000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $5.5 million in Q3 2023 and bottomed at $89000.0 in Q2 2022.
- The 5-year median for Share-based Compensation is $670000.0 (2025), against an average of $972562.5.
- The widest annual swing landed in 2023, when Share-based Compensation jumped 5855.91%; it then slumped 84.47% in 2024.
- A 5-year view of Share-based Compensation shows it stood at $182000.0 in 2022, then soared by 1003.3% to $2.0 million in 2023, then plunged by 58.22% to $839000.0 in 2024, then fell by 16.33% to $702000.0 in 2025, then dropped by 9.12% to $638000.0 in 2026.
- The last three Share-based Compensation figures came in at $638000.0 (Q1 2026), $702000.0 (Q4 2025), and $531000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Allurion Technologies | - | - | 1.23 Mn | 638,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 638,000.00 |
| Mar 31, 2026 | 638,000.00 |
| Dec 31, 2025 | 702,000.00 |
| Dec 31, 2025 | 702,000.00 |
| Sep 30, 2025 | 531,000.00 |
| Sep 30, 2025 | 531,000.00 |
| Jun 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | 897,000.00 |
| Mar 31, 2025 | 897,000.00 |
| Dec 31, 2024 | 839,000.00 |
| Dec 31, 2024 | 839,000.00 |
| Sep 30, 2024 | 860,000.00 |
| Sep 30, 2024 | 860,000.00 |
| Jun 30, 2024 | 805,000.00 |
| Jun 30, 2024 | 805,000.00 |
| Mar 31, 2024 | 552,000.00 |
| Mar 31, 2024 | 552,000.00 |
| Dec 31, 2023 | 2.01 Mn |
| Dec 31, 2023 | 2.01 Mn |
| Sep 30, 2023 | 5.54 Mn |
| Sep 30, 2023 | 5.54 Mn |
| Jun 30, 2023 | 401,000.00 |
| Jun 30, 2023 | 401,000.00 |
| Mar 31, 2023 | 409,000.00 |
| Mar 31, 2023 | 409,000.00 |
| Dec 31, 2022 | 182,000.00 |
| Dec 31, 2022 | 182,000.00 |
| Sep 30, 2022 | 93,000.00 |
| Sep 30, 2022 | 93,000.00 |
| Jun 30, 2022 | 89,000.00 |
| Jun 30, 2022 | 89,000.00 |